Adaptive Biotechnologies Quote - ADPT

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.10

Bid

7.60

Offer

8.80

Volume

0.00 Day's Range 0.00

2.28 52 Week Range 8.94

Market Cap

1.195B

Previous Close

8.10

Open

Last Trade

7.92

Last Trade Time

20:48:56

Financial Volume

VWAP

Average Volume (3m)

1,408,294

Shares Outstanding

147,579,486

Dividend Yield

PE Ratio

-5.31

Earnings Per Share (EPS)

-1.53

Revenue

170.28M

Net Profit

-225.25M

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.adaptivebiotech.com

Headquarters

Olympia, Washington, USA

Founded

Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was US$8.10. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of US$ 2.28 to US$ 8.94.

Adaptive Biotechnologies currently has 147,579,486 shares in issue. The market capitalisation of Adaptive Biotechnologies is US$1.20 billion. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -5.31.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.418	-4.90725522423	8.518	8.94	7.86	1294591	8.27685368	CS
4	0.44	5.74412532637	7.66	8.94	6.97	1634545	8.12772842	CS
12	1.66	25.7763975155	6.44	8.94	5.805	1408294	7.40397936	CS
26	3.63	81.2080536913	4.47	8.94	3.981	1280366	6.21804515	CS
52	4.06	100.495049505	4.04	8.94	2.28	1405680	4.73411195	CS
156	-4.89	-37.6443418014	12.99	15.19	2.28	1309505	6.43587582	CS
260	-18.4	-69.4339622642	26.5	71.25	2.28	1149121	16.48248398	CS

ADPT - Frequently Asked Questions (FAQ)

What is the current Adaptive Biotechnologies share price?

The current share price of Adaptive Biotechnologies is US$ 8.10

How many Adaptive Biotechnologies shares are in issue?

Adaptive Biotechnologies has 147,579,486 shares in issue

What is the market cap of Adaptive Biotechnologies?

The market capitalisation of Adaptive Biotechnologies is USD 1.2B

What is the 1 year trading range for Adaptive Biotechnologies share price?

Adaptive Biotechnologies has traded in the range of US$ 2.28 to US$ 8.94 during the past year

What is the PE ratio of Adaptive Biotechnologies?

The price to earnings ratio of Adaptive Biotechnologies is -5.31

What is the cash to sales ratio of Adaptive Biotechnologies?

The cash to sales ratio of Adaptive Biotechnologies is 7.02

What is the reporting currency for Adaptive Biotechnologies?

Adaptive Biotechnologies reports financial results in USD

What is the latest annual turnover for Adaptive Biotechnologies?

The latest annual turnover of Adaptive Biotechnologies is USD 170.28M

What is the latest annual profit for Adaptive Biotechnologies?

The latest annual profit of Adaptive Biotechnologies is USD -225.25M

What is the registered address of Adaptive Biotechnologies?

The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267

What is the Adaptive Biotechnologies website address?

The website address for Adaptive Biotechnologies is www.adaptivebiotech.com

Which industry sector does Adaptive Biotechnologies operate in?

Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UOKAMDJM Ltd	US$ 0.245 (63.33%)	11.69M
PTIXProtagenic Therapeutics Inc	US$ 0.3895 (40.97%)	23.42M
LNKSLinkers Industries Ltd	US$ 0.85 (30.77%)	53
GCLGCL Global Holdings Ltd	US$ 2.59 (28.22%)	586
IKTInhibikase Therapeutics Inc	US$ 2.91 (28.19%)	10
SPGCSacks Parente Golf Inc	US$ 0.1058 (-44.32%)	12.25M
SYRESpyre Therapeutics Inc	US$ 11.00 (-38.68%)	4
EVCMEverCommerce Inc	US$ 6.20 (-36.28%)	7
OPCHOption Care Health Inc	US$ 22.01 (-35.19%)	21
EOLSEvolus Inc	US$ 9.32 (-35.01%)	8
SUNESUNation Energy Inc	US$ 0.21 (-12.50%)	48.55M
BTOGBit Origin Ltd	US$ 0.4067 (27.37%)	43.74M
AGMHAGM Group Holdings Inc	US$ 0.1206 (-9.32%)	25.03M
PTIXProtagenic Therapeutics Inc	US$ 0.3873 (40.17%)	23.43M
SPGCSacks Parente Golf Inc	US$ 0.1058 (-44.32%)	12.25M